Literature DB >> 27493602

The Transition From Pediatric to Adult Inflammatory Bowel Disease Care.

Stacy A Kahn1.   

Abstract

Year:  2016        PMID： 27493602      PMCID： PMC4971825     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Robert Baldassano; George Ferry; Anne Griffiths; David Mack; James Markowitz; Harland Winter
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-03       Impact factor: 2.839

2.  Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool.

Authors:  Eric I Benchimol; Thomas D Walters; Miriam Kaufman; Karen Frost; Karoline Fiedler; Zenaida Chinea; Mary Zachos
Journal:  Inflamm Bowel Dis       Date:  2010-11-05       Impact factor: 5.325

3.  Transition of Care in Inflammatory Bowel Disease.

Authors:  Bincy P Abraham; Stacy A Kahn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

4.  Barriers and facilitators to successful transition from pediatric to adult inflammatory bowel disease care from the perspectives of providers.

Authors:  Christine W Paine; Natalie B Stollon; Matthew S Lucas; Lauren D Brumley; Erika S Poole; Tamara Peyton; Anne W Grant; Sophia Jan; Symme Trachtenberg; Miriam Zander; Petar Mamula; Christopher P Bonafide; Lisa A Schwartz
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

5.  Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease.

Authors:  Michele Herzer; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

6.  Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial.

Authors:  Rachel N Greenley; Amitha P Gumidyala; Eve Nguyen; Jill M Plevinsky; Natasha Poulopoulos; Molly M Thomason; Jennifer G Walter; Andrea A Wojtowicz; Ellen Blank; Ranjana Gokhale; Barbara S Kirschner; Adrian Miranda; Joshua D Noe; Michael C Stephens; Steven Werlin; Stacy A Kahn
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

7.  Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.

Authors:  Yvette Leung; Melvin B Heyman; Uma Mahadevan
Journal:  Inflamm Bowel Dis       Date:  2010-12-16       Impact factor: 5.325
  7 in total
  3 in total

1.  Transition From Pediatric to Adult Care by Young Adults With Chronic Granulomatous Disease: The Patient's Viewpoint.

Authors:  Rachel Margolis; Lori Wiener; Maryland Pao; Harry L Malech; Steven M Holland; Patricia Driscoll
Journal:  J Adolesc Health       Date:  2017-09-22       Impact factor: 5.012

2.  Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn's and Colitis Canada.

Authors:  Nancy Fu; Natasha Bollegala; Kevan Jacobson; Karen I Kroeker; Karen Frost; Waqqas Afif; Wael El-Matary; Sharyle A Fowler; Anne M Griffiths; Hien Q Huynh; Prévost Jantchou; Ahmer Karimuddin; Geoffrey C Nguyen; Anthony R Otley; Christina Pears; Cynthia H Seow; Alene Toulany; Claudia Tersigni; Joanne Tignanelli; John K Marshall; Monica Boctor; Tawnya Hansen; Chandni Pattni; Andrew Wong; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2022-03-26

3.  Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease.

Authors:  Antje Timmer; Jenny Peplies; Max Westphal; Birgit Kaltz; Antje Ballauff; Martin Claßen; Martin W Laass; Sibylle Koletzko
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.